H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. Census population 8,336,817. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New York clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New York storefront.
361 HCT/P Compliant Tissue Products in New York, NY for clinics & physicians. Exclusively 361 HCT/P compli… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 19.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. Together those PLACES numbers are why a city of 1M+ still needs separate PRP and CTP protocols. 361 hctp compliant products inventory is national; utilization is JK-local.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)JK reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in New York is 11.9% or not. PLACES is planning data. The LCD is the claim.
If you already buy 361 hctp compliant products elsewhere, use this page as a check: homologous-use language, current National Government Services (NGS) article IDs, and PLACES 11.9% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 11.9% of adults — about even with the U.S. 12% figure. Obesity is 25.1%; arthritis is 19.9%. That is place-level BRFSS modeling, not a clinic census and not a New York trial.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in New York.
This URL is written for healthcare providers shopping distribution. Patient-facing ads must follow your state medical board and FTC rules. Do not copy distributor language into consumer ads that imply guaranteed healing.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. National Government Services (NGS) LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
If you operate in New York and another MAC state, say it on the first call. JK will not port 1:1. We would rather split utilization than watch a sister clinic copy New York tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in New York, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New York is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New York — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New York. Useful for joint-program math; still needs a diagnosis and privileging.
No New York storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.